SCHEMBL29132483

SCHEMBL29132483

COC(=O)CNc1c(OCc2ccccc2)cc2c(c1F)C[C@H](NC(=O)OC(C)(C)C)C=C2C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 2/20 0.34
PTGER1 P34995 2/20 0.34
CYP2C9 P11712 1/20 0.34
KMT2A Q03164 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CCNT1 O60563 1/20 0.33
CCNA2 P20248 1/20 0.33
CDK2 P24941 1/20 0.33
CDK9 P50750 1/20 0.33
CCNA1 P78396 1/20 0.33
PDE4B Q07343 1/20 0.33
BRD4 O60885 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
SMPD1 P17405 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
PAX8 Q06710 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30683988 1.00 RORC (0.34) RORCPTGER1CYP2C9KMT2AL3MBTL1
SCHEMBL25339483 0.94 RORC (0.35) RORCPTGER1CYP2C9KMT2AL3MBTL1
SCHEMBL29132491 0.85 NFKB1 (0.38) RORCPTGER1CYP2C9KMT2AL3MBTL1
SCHEMBL30683975 0.85 NFKB1 (0.38) RORCPTGER1CYP2C9KMT2AL3MBTL1
SCHEMBL29132485 0.82 CYP2C9 (0.33) RORCPTGER1CYP2C9KMT2AL3MBTL1
SCHEMBL30352483 0.81 KMT2A (0.39) RORCPTGER1CYP2C9KMT2AL3MBTL1
SCHEMBL29626343 0.80 KMT2A (0.39) RORCPTGER1CYP2C9KMT2AL3MBTL1
SCHEMBL25339683 0.78 PTGER1 (0.34) RORCPTGER1CYP2C9KMT2AL3MBTL1
SCHEMBL25337822 0.78 NFKB1 (0.39) RORCPTGER1CYP2C9KMT2AL3MBTL1
SCHEMBL29626353 0.76 PDE4B (0.33) RORCPTGER1CYP2C9KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250122160-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF CALICO LIFE SCIENCES LLC (US) 2025-04-17 US disclosed
CN-116829555-A Protein tyrosine phosphatase inhibitors and methods of use thereof 卡里科生命科学有限责任公司 2023-09-29 CN disclosed
EP-4211122-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF Calico Life Sciences LLC (US) 2023-07-19 EP disclosed
WO-2022056281-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF CALICO LIFE SCIENCES LLC (US) 2022-03-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250122160-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOF PTPN1, PTPN2, PTPN18 RORC 1878/4885PTGER1 4009/4885CYP2C9 4051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.